Impact of Positive Surgical Margins After Radical Prostatectomy Differs by Disease Risk Group

Journal of Urology

Volumn 183, Issue 1, 2010, Pages 145-150

  Alkhateeb, Sultan ^a   Alibhai, Shabbir ^a   Fleshner, Neil ^a   Finelli, Antonio ^a   Jewett, Michael ^a   Zlotta, Alexandre ^a   Nesbitt, Michael ^a   Lockwood, Gina ^a   Trachtenberg, John ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

disease progression; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOCHEMISTRY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT;

ADULT; AGED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 71449101531     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.132     Document Type: Article

References (27)

1. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
2. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555
3. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter?. The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 179 (2008) S47
4. Vis A.N., Schroder F.H., and van der Kwast T.H. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 50 (2006) 258
5. Karakiewicz P.I., Eastham J.A., Graefen M., et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66 (2005) 1245
6. Pfitzenmaier J., Pahernik S., Tremmel T., et al. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?. BJU Int 102 (2008) 1413
7. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 281 (1999) 1395
8. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528
9. Grafen M., Noldus J., Pichlmeier U., et al. Early prostate-specific antigen relapse after radical retroubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol 36 (1999) 21
10. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 148 (1992) 1549
11. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822
12. Amling C.L., Bergstralh E.J., Blute M.L., et al. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?. J Urol 165 (2001) 1146
13. Stephenson A., Kattan M.W., Eastham J., et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24 (2006) 3973
14. Eastham J.A., Kattan M.W., Riedel E., et al. Variation among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 170 (2003) 2292
15. Cheng L., Darson M.F., Bergstralh E.J., et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 86 (1999) 1775
16. D'Amico A.V., Whittington R., Malkowicz S.B., et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154 (1995) 131
17. Ohori M., Wheeler T.M., Kattan M., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154 (1995) 1818
18. Palisaar R.J., Graefen M., Karakiewicz P.I., et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol 41 (2002) 155
19. Kattan M.W., Wheeler T.M., Scardino P.T., et al. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499
20. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572
21. Thompson Jr. I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329
22. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181 (2009) 956
23. Grossfeld G.D., Tigrani V.S., Nudell D., et al. Management of a positive margin after radical prostatectomy: decision analysis. J Urol 164 (2000) 93
24. Fesseha T., Sakr W., Grignon D., et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 158 (1997) 2176
25. Pettus J.A., Weight C.J., Thompson C.J., et al. Biochemical failure in men following radical prostatectomy: impact of surgical margins status and location. J Urol 172 (2004) 129
26. Eastham J.A., Kuroiwa K., Ohori M., et al. Prognostic significance of location of margins in radical prostatectomy specimens. Urology 70 (2008) 965
27. Johansson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713